CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

Coordinating Specialty Care without Fragmenting Access

By

Life Sciences Review | Monday, August 17, 2026

Even after a specialty therapy is prescribed, treatment can stall during benefit verification, prior authorization, financial support, dispensing, delivery or clinical follow-up. Every handoff creates another opportunity for missing documentation, delayed responses, duplicated outreach or confusion over who owns the case. When responsibility is divided across providers, it also becomes difficult to see where time is being lost—whether in documentation, coverage review, distribution or follow-up. For executives evaluating an integrated pharmacy network, having multiple services under one brand is only part of the picture. What matters is whether the provider can keep a case moving across payer, prescriber, pharmacy and patient workflows without requiring each party to piece the information together again.


Much of the work around access comes down to preparing the case correctly from the start. Providers need to gather clinical records early, confirm coverage requirements, resolve missing information and make sure the submission is ready before it moves forward. Appeals and copay support should stay connected to the same patient record instead of being pushed into a separate queue. When a case stalls, buyers also need to know who is responsible and when that person will step in. Offering a long list of services means little if the authorization process remains fragmented behind the scenes.


Securing approval does not end the coordination challenge. Specialty dispensing, home delivery, infusion coordination and patient education all need to follow the same treatment plan. Medication history and delivery requirements should remain visible across the network, with prescribers kept informed when something changes that could affect therapy. Temperature controls, scheduling windows, failed-delivery procedures and chain-of-custody records are part of that responsibility. So is responding when a dose changes or a patient reports a side effect. Patients should not have to repeat the same information simply because their case has moved from one part of the organization to another.


“Its local model covers benefit investigation, prior authorization, financial assistance and adherence follow-up, with bilingual teams supporting communication with patients and medical offices.”


A centralized program also has to work in the market where patients and medical offices actually use it. Language access and knowledge of local payer procedures can affect everything from document collection and patient outreach to case escalation and communication with medical offices. National workflows may create unnecessary rework when they fail to account for local coverage requirements or staffing realities. Buyers should therefore understand how much of the work is handled by teams with direct knowledge of the market and how much is routed through a distant center that depends on scripts and callbacks.


Accreditation is important, but buyers still need to understand how quality is managed from day to day. Routine self-audits, documented medication-safety controls, staff training and corrective-action records provide a clearer picture. Reporting should also allow managed care organizations and manufacturers to see where approvals are being delayed, where adherence gaps are appearing and which complaints or exceptions remain unresolved. Each party needs enough visibility to act without sending the patient through another round of coordination. Contract terms can support this by clearly defining reporting cadence and ownership of exceptions, turning reporting into an active management tool rather than a retrospective count of activity.


Alivia Health brings specialty pharmacy, pharmaceutical hub services, home delivery and infusion coordination together within one network for buyers serving Puerto Rico. Its local model covers benefit investigation, prior authorization, financial assistance and adherence follow-up, with bilingual teams supporting communication with patients and medical offices. The network also provides islandwide specialty delivery and coordinates home infusion with nursing providers. Accreditation-backed quality controls and reporting to managed care partners give buyers greater visibility into the service. For organizations looking for one accountable provider across access, fulfillment, therapy support and payer coordination, Alivia Health offers a practical fit.


Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/deep-dive/coordinating-specialty-care-without-fragmenting-access-nwid-3670.html